Factors associated with death among HIV-uninfected TB patients in Thailand, 2004-2006

Tropical Medicine and International Health

Volumn 14, Issue 11, 2009, Pages 1338-1346

  Amnuaiphon, Waraya ^b   Anuwatnonthakate, Amornrat ^c   Nuyongphak, Prungsri ^d   Sinthuwatanawibool, Chalinthorn ^c   Rujiwongsakorn, Sadudee ^e   Nakara, Prapa ^e   Komsakorn, Sitijate ^f   Wattanaamornkiet, Wanpen ^g   Moolphate, Saiyud ^h   Chiengsorn, Navarat ⁱ   Kaewsaard, Samroui ^j   Nateniyom, Sriprapa ^c   Varma, Jay K ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Vachira Phuket Hospital   (Thailand)

^c MINISTRY OF PUBLIC HEALTH   (Thailand)

^d Thalang Hospital   (Thailand)

^e Phuket Provincial Health Office   (Thailand)

^f Chiang Rai Provincial Public Health Office   (Thailand)

^g Office of Disease Prevention and Control 7   (Thailand)

^h RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

ⁱ Bangkok Metropolitan Health Administration   (Thailand)

^j Bamrasnaradura Infectious Disease Institute   (Thailand)

more..

Author keywords

Muerte; No infectados por VIH; Tailandia; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

CONFIDENCE INTERVAL; DATA PROCESSING; DISEASE CONTROL; DISEASE PREVALENCE; EPIDEMIC; HEALTH GEOGRAPHY; HEALTH MONITORING; HEALTH RISK; HUMAN IMMUNODEFICIENCY VIRUS; MORTALITY; MULTIVARIATE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

ADOLESCENT; AGED; ARTICLE; CHILD; COMORBIDITY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; PRESCHOOL CHILD; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; THAILAND; TREATMENT OUTCOME; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HIV SERONEGATIVITY; HUMANS; INFANT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; THAILAND; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

ASIA; EURASIA; SOUTHEAST ASIA; THAILAND;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 70350017868     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2009.02376.x     Document Type: Article

References (43)

1. Akksilp S, Karnkawinpong O, Wattanaamornkiat W et al. (2007) Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand. Emerging Infectious Diseases 13, 1001 1007.
2. Allan WG, Snell NJ, Hill LE, Fayers PM, Scadding JG Fox W (1981) A survey of deaths in Hong Kong attributed to tuberculosis. Tubercle 62, 1 11.
3. Anuwatnonthakate A, Limsomboon P, Nateniyom S et al. (2008) Directly observed therapy and improved tuberculosis treatment outcomes in Thailand. PLoS ONE 3, e3089.
4. Bandele EO Olude IO (1985) An analysis of deaths due to tuberculosis at the Lagos University Teaching Hospital. Journal of the National Medical Association 77, 643 646.
5. Bustamante-Montes LP, Escobar-Mesa A, Borja-Aburto VH, Gomez-Munoz A Becerra-Posada F (2000) Predictors of death from pulmonary tuberculosis: the case of Veracruz, Mexico. International Journal of Tuberculosis and Lung Diseaes 4, 208 215.
6. Cauchie P, Delwiche F, Efira A, Vincken W, Volckaert A Decaux G (1988) Tuberculosis: cause of death in Brussels. Annales de medecine interne 139, 132 133.
7. Dewan PK, Arguin PM, Kiryanova H et al. (2004) Risk factors for death during tuberculosis treatment in Orel, Russia. International Journal of Tuberculosis and Lung Diseases 8, 598 602.
8. Domingos MP, Caiaffa WT Colosimo EA (2008) Mortality, TB/HIV co-infection, and treatment dropout: predictors of tuberculosis prognosis in Recife, Pernambuco State, Brazil. Cadernos de saude publica/Ministerio da Saude, Fundacao Oswaldo Cruz, Escola Nacional de Saude Publica 24, 887 896.
9. Enarson DA, Grzybowski S Dorken E (1978) Failure of diagnosis as a factor in tuberculosis mortality. Canadian Medical Association Journal 24, 1520 1522.
10. Fielder JF, Chaulk CP, Dalvi M, Gachuhi R, Comstock GW Sterling TR (2002) A high tuberculosis case-fatality rate in a setting of effective tuberculosis control: implications for acceptable treatment success rates. International Journal of Tuberculosis and Lung Diseaes 6, 1114 1117.
11. Floyd K Wilkinson D (1997) Tuberculosis in the HIV/AIDS era: interactions, impacts and solutions. AIDS Analysis Africa 7, 5 7.
12. Garcia-Garcia Mde L, Ponce-De-Leon A, Garcia-Sancho MC et al. (2002) Tuberculosis-related deaths within a well-functioning DOTS control program. Emerging Infectious Diseases 8, 1327 1333.
13. Hooi LN Goh KY (1995) A hospital based audit of tuberculosis deaths. The Medical Journal of Malaysia 50, 306 313.
14. Jittimanee S, Vorasingha J, Mad-asin W, Nateniyom S, Rienthong S Varma JK (2009) Tuberculosis in Thailand: epidemiology and program performance, 2001-2005. Tropical Medicine and International Health 13, 436 442.
15. Kapella BK, Anuwatnonthakate A, Komsakorn S et al. (2009) Directly observed therapy is associated with reduced default among foreign TB patients in Thailand. International Journal of Tuberculosis and Lung Diseases 13, 232 237.
16. Maher D Raviglione M (2005) Global epidemiology of tuberculosis. Clinics in Chest Medicine 26, 167 182.
17. Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A Sungkanuparph S (2006) Survival rate and risk factors of mortality among HIV/tuberculosis- coinfected patients with and without antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 43, 42 46.
18. Mathew TA, Ovsyanikova TN Shin SS (2006) Causes of death during tuberculosis treatment in Tomsk Oblast, Russia. International Journal of Tuberculosis and Lung Diseases 10, 857 863.
19. Naalsund A, Heldal E, Johansen B, Kongerud J Boe J (1994) Deaths from pulmonary tuberculosis in a low-incidence country. Journal of Internal Medicine 236, 137 142.
20. Nathanson E, Lambregts-van Weezenbeek C, Rich ML et al. (2006) Multidrug-resistant tuberculosis management in resource-limited settings. Emerging Infectious Diseases 12, 1389 1397.
21. Olle-Goig JE (2000) Patients with tuberculosis in Bolivia: why do they die? Revista panamericana de salud publica 8, 151 155.
22. Oursler KK, Moore RD, Bishai WR, Harrington SM, Pope DS Chaisson RE (2002) Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. Clinical Infectious Diseases 15, 752 759.
23. Pablos-Mendez A, Sterling TR Frieden TR (1996) The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. Journal of the American Medical Association 16, 1223 1228.
24. Pelaquin MH, Souza e Silva R Ribeiro SA (2007) Factors associated with death by tuberculosis in the eastern part of Sao Paulo city. Jornal Brasileiro de Pneumologia 33, 311 317.
25. Rao VK, Iademarco EP, Fraser VJ Kollef MH (1998) The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis. Chest 114, 1244 1252.
26. Sanguanwongse N, Cain KP, Suriya P et al. (2008) Antiretroviral therapy for HIV-infected tuberculosis patients saves lives but needs to be used more frequently in Thailand. Journal of Acquired Immune Deficiency Syndromes 48, 181 189.
27. Santha T, Garg R, Frieden TR et al. (2002) Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India. International Journal of Tuberculosis and Lung Diseases 6, 780 788.
28. Siriarayapon P, Yanai H, Glynn JR, Yanpaisarn S Uthaivoravit W (2002) The evolving epidemiology of HIV infection and tuberculosis in northern Thailand. Journal of Acquired Immune Deficiency Syndrome 31, 80 89.
29. Srisuwanvilai LO, Monkongdee P, Podewils LJ et al. (2008) Performance of the BACTEC MGIT 960 compared with solid media for detection of Mycobacterium in Bangkok, Thailand. Diagnostic Microbiology and Infectious Disease 61, 402 407.
30. Stop TB Partnership WHO (2006) The Global Plan to Stop TB, 2006-2015. Actions for life: towards a world free of tuberculosis. International Journal of Tuberculosis and Lung Diseases 10, 240 241.
31. Sungkanuparph S, Eampokalap B, Chottanapund S, Thongyen S Manosuthi W (2007) Impact of drug-resistant tuberculosis on the survival of HIV-infected patients. International Journal of Tuberculosis and Lung Diseases 11, 325 330. (Pubitemid 46447442)
32. Tangcharoensathien V, Faramnuayphol P, Teokul W, Bundhamcharoen K Wibulpholprasert S (2006) A critical assessment of mortality statistics in Thailand: potential for improvements. Bulletin of the World Health Organization 84, 233 238.
33. Tansuphasawadikul S, Saito W, Kim J et al. (2007) Outcomes in HIV-infected patients on antiretroviral therapy with tuberculosis. The Southeast Asian Journal of Tropical Medicine and Public Health 38, 1053 1060.
34. Varma JK, Wiriyakitjar D, Nateniyom S et al. (2007) Evaluating the potential impact of the new Global Plan to Stop TB: Thailand, 2004-2005. Bulletin of the World Health Organization 85, 586 592.
35. Walpola HC, Siskind V, Patel AM, Konstantinos A Derhy P (2003) Tuberculosis-related deaths in Queensland, Australia, 1989-1998: characteristics and risk factors. International Journal of Tuberculosis and Lung Diseases 7, 742 750.
36. WHO (2003) Treatment of Tuberculosis: Guidelines for National Programmes, 3rd edn. WHO, Geneva.
37. WHO (2004) Toman's Tuberculosis Case Detection, Treatment, and Monitoring: Questions and Answers, 2nd edn. WHO, Geneva.
38. WHO (2008a) Global Tuberculosis Control: Surveillance, Planning, Financing. WHO, Geneva.
39. WHO (2008b) Guidelines for the Programmatic Management of Drug-resistant Tuberculosis. WHO, Geneva.
40. WHO & International Union Against Tuberculosis and Lung Disease (2008) Anti-Tuberculosis Drug Resistance in the world. Report No. 4. WHO, Geneva.
41. WHO South-East Asia Regional Office (2008) Fourth Review of the National Tuberculosis Programme in Thailand, 16-25 July 2007. WHO, New Delhi.
42. Xie G, Cheng X Xu X (2001) Risk factors of chronic obstructive pulmonary disease in patients with chronic bronchitis. Zhonghua yi xue za zhi 81, 1356 1359.
43. Zafran N, Heldal E, Pavlovic S, Vuckovic D Boe J (1994) Why do our patients die of active tuberculosis in the era of effective therapy? International Journal of Tuberculosis and Lung Diseases 75, 329 333.